Supernus Pharmaceuticals Inc (SUPN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
Supernus Pharmaceuticals, Inc. (SUPN)
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.supernus.com
Company Research
Source: Yahoo! Finance
Operating Earnings (GAAP): $40.9 million for Q3 2024, up from $8.1 million in Q3 2023. Net Earnings (GAAP): $38.5 million for Q3 2024, or $0.69 per diluted share, compared to a net loss of $16 million in Q3 2023. Adjusted Operating Earnings (Non-GAAP): $67.7 million for Q3 2024, up from $37.3 million in Q3 2023. Cash and Marketable Securities: $403.2 million as of September 30, 2024. Revenue Guidance for 2024: Raised to $630 million to $650 million. R&D and SG&A Expenses: $98.8 million for Q3 2024, down from $105.4 million in Q3 2023. Prescription Growth: KVIS prescriptions grew 19% with net sales up 68% in Q3 2024. Net Sales of Key Products: KVIS net sales were $62 million; Recovery net sales were $36 million, up 8% from Q3 2023. Warning! GuruFocus has detected 9 Warning Signs with SUPN. Release Date: November 04, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Supernus Pharmaceuticals Inc ( NASDAQ:SUPN )
Show less
Read more
Impact Snapshot
Event Time:
SUPN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SUPN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SUPN alerts
High impacting Supernus Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
SUPN
News
- Supernus Pharmaceuticals to Participate in the 2024 Jefferies London Healthcare ConferenceGlobeNewswire
- Supernus Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]Yahoo! Finance
- Supernus (SUPN) Reports Q3 Earnings: What Key Metrics Have to Say [Yahoo! Finance]Yahoo! Finance
- Supernus Pharmaceuticals (SUPN) Beats Q3 Earnings and Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- Supernus Announces Third Quarter 2024 Financial ResultsGlobeNewswire
SUPN
Earnings
- 11/4/24 - Beat
SUPN
Sec Filings
- 11/14/24 - Form SC
- 11/12/24 - Form 4
- 11/12/24 - Form 4
- SUPN's page on the SEC website